Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance

Gut

Volumn 52, Issue 7, 2003, Pages 975-980

  McCarthy, J ^b   O'Mahony, L ^b   O'Callaghan, L ^b   Sheil, B ^b   Vaughan, E E ^c   Fitzsimons, N ^c   Fitzgibbon, J ^b   O'Sullivan, G C ^b   Kiely, B ^b   Collins, J K ^b   Shanahan, F ^a,b  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATTENUATION; BIFIDOBACTERIUM LONGUM INFANTIS; CONTROLLED STUDY; ENTEROCOLITIS; FECES ANALYSIS; FEMALE; HISTOLOGY; IMMUNE RESPONSE; INTESTINE FLORA; KNOCKOUT MOUSE; LACTOBACILLUS SALIVARIUS; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; REDUCTION; SAMPLING; SPLEEN CELL;

ANIMALS; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROINTESTINAL TRANSIT; INTERLEUKIN-10; INTESTINES; LACTOBACILLUS; MICE; MICE, KNOCKOUT; MILK; PEYER'S PATCHES; PROBIOTICS; RANDOM ALLOCATION; SPLEEN;

EID: 0038121809     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.7.975     Document Type: Article

References (30)

1. Shanahan F. Probiotics and Inflammatory Bowel disease: Is there a scientific rationale? Inflamm Bowel Dis 2000;6:107-15.
2. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
3. Shanahan F. Gene-targeted immunologic knockouts: new models of inflammatory bowel disease. Gastroenterology 1994;17:312-14.
4. -/-) mice and intestinal inflammation. AJP-Gastrointest Liver Physiol 2000;278:G289-33.
5. Fuller R. Probiotics in human medicine. Gut 1991;32:439-42.
6. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998;42:2-7.
7. Dunne C, Murphy L, Flynn S, et al. Probiotics from myth to reality. Demonstration of functionality in animal models of disease and human clinical trials. Antonie van Leeuwenhoek 1999;76:279-92.
8. O'Mahony L, Feeney M, O'Halloran S, et al. Probiotic impact on microbial flora, inflammation, and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 2001;15:1219-25.
9. Shanahan F. Therapeutic manipulation of gut flora. Science 2000;289:1311-2.
10. Hooper LV, Wong MH, Gordon JI, et al. Molecular analysis of commensal host/ microbial relationships in the intestine. Science 2001;291:881-4
11. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus sp prevents development of enterocolitis in interleukin-10 deficient mice. Gastroenterology 1999;116:1107-14.
12. + TH1-like responses. J Clin Invest 1996;98:1010-20.
13. Davidson NJ, Hudak SA, Lesley RE, et al. IL-12, but not IFN- γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 1998;161:3143-9.
14. Davidson NJ, Fort M, Muller W, et al. Chronic colitis in IL-10 -/- mice: insufficient counter regulation of a Th1 response. Intern Rev Immunol 2000;19:91-121.
15. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host- specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854-9.
16. Heilig HG, Zoetendal EG, Vaughan EE, et al. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002;68:114-23.
17. Satokari RM, Vaughan EE, Akkermans ADL, et al. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001;67:504-13.
18. Lane DJ. 16S/23S rDNA sequencing, In: Stackebrandt E, Goodfellow M, eds. Nucleic acid techniques in bacterial systematics. Chichester, UK: J Wiley and Sons, 115-75.
19. Sanguinetti CJ, Dias Neto E, Simpson AJG. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994;17:915-19.
20. Hane BG, Jager K, Drexler H. The Pearson product-moment correlation coefficient is better suited for identification of DNA fingerprint profiles than band matching algorithms. Electrophoresis 1993;14:967-72.
21. Dunne C, O'Mahony L, Murphy L, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001;73:386-92S.
22. Murphy L, Dunne C, Kiely B, et al. In vivo assessment of potential probiotic Lactobacillus salivarius strains: evaluation of their establishment, persistence, and localisation in the murine gastrointestinal tract. Micro Ecol Health Dis 1999;11:149-57.
23. Dugas B, Mercenier A, Lenoir-Wijnkoop I, et al. Immunity and Probiotics. Immunol Today 1999;20:387-90.
24. O'Mahony L, Feeney M, Dunne C, et al. Probiotic bacteria and the human immune system. In: Buttress J, ed. Functional foods II: claims and evidence. Royal Society of Chemistry, 2000:63-70.
25. Yasui H, Shida K, Matsuzaki T, et al. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 1999;76:383-9.
26. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF- α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-82.
27. Romagnani P, Annunziato F, Bacceri Mc, et al. T cells and cytokines in Crohn's disease. Curr Opin Immunol 1997;9:793-9.
28. Strober W, Kelsall B, Fuss I, et al. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:6-14.
29. Schultz M, Sartor RB. Probiotics and inflammatory bowel disease. Am J Gastroenterology 2000;95:S19-21.
30. Murphy L, Byrne F, Collins JK, et al. Evaluation and characterisation of probiotic therapy in the CD45Rbhi transfer model of colitis. Gastroenterology 1999;116:G3382.